Early progression of non-center diabetic macular edema after phacoemulsification
Official title: Assessment of Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
Run by Ain Shams University · NCT07038967 · Data updated 2026-11-12
This will see if non-center-involving diabetic macular edema worsens in the early weeks after cataract surgery in adults with diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | June 29, 2025 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | July 1, 2025 |
| Trial ID | NCT07038967 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) with diabetes who have Grade I–II nuclear cataract and non-center-involving diabetic macular edema and are planned for phacoemulsification without severe diabetic retinopathy are ideal candidates.
✕Probably not a fit
Patients with severe NPDR/PDR, traumatic or mature cataract, marked asymmetry between eyes, those needing combined phacotrabeculectomy, or those who experience surgical complications are unlikely to gain direct benefit from this observational protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with diabetes who have Grade I–II nuclear cataract and non-center-involving diabetic macular edema will be followed before and after phacoemulsification using color fundus photography, fluorescein angiography, and optical coherence tomography. Imaging will be performed preoperatively and at defined early postoperative visits to document any change in retinal thickness or leakage. Patients with severe non-proliferative or proliferative diabetic retinopathy, traumatic or mature cataract, marked asymmetry between eyes, planned combined glaucoma surgery, or surgical complications are excluded. The single-center observational design at Ain Shams University will describe the frequency and timing of early postoperative progression of NCIDME.
Why it matters
Potential benefit: If successful, findings could help eye doctors detect and manage early worsening of non-center DME after cataract surgery to better preserve vision.
How similar studies have gone: Prior reports have described diabetic macular edema after cataract surgery but prospective data specifically on early progression of non-center-involving DME are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Both sexes. * Patients with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME). Exclusion Criteria: * Traumatic cataract. * Severe Non-Proliferative/ Proliferative Diabetic Retinopathy. * Marked Asymmetry of retinopathy between both eyes. * Mature senile cataract or severe lens opacity. * Potentiality to have Phacotrabeculectomy surgery. * Complications during or after the surgery.
Where it's running
-
Ain Shams University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Hatem F Abd Elfatah, MD
- Email: tito78@yahoo.com
- Phone: 00201001859927
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blepharoptosis After Repeated Anti-VEGF Injections in One Eye
This study tests whether repeated intravitreal anti-VEGF injections in one eye affect eyelid position compared with the untreated fellow eye.
-
Ultrasound check of IOL tilt after cataract surgery
A noninvasive ultrasound test is used to see if an intraocular lens tilts or decentrates after cataract surgery in adults.
-
Testing Different Doses of BI 3812465 in Diabetic Macular Edema
Researchers are testing whether varying doses of BI 3812465 can be tolerated in adults with center-involved diabetic macular edema.
-
Comparing AVT29 and Eylea HD for diabetic macular edema
This study will test whether AVT29 works as well and is as safe as Eylea HD in adults with center-involving diabetic macular edema who have reduced vision.
-
Daily oral Kamuvudine-9 (K9) for diabetic macular edema
This trial will test whether taking oral K9 twice daily is safe and improves vision in adults with diabetic macular edema.
-
RO7823653 injections, alone or with faricimab, for diabetic macular edema
This research tests injections of RO7823653, given alone or with faricimab, in people with diabetic macular edema to see if the medication is safe and how the eye handles it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.